Get started
Author

Mariko Yoneyama-Hirozane

Observed names: M Yoneyama-Hirozane, M. Yoneyama-Hirozane, Mariko Hirozane, Yoneyama-Hirozane, Mariko
ORCID: 0000-0003-3403-114X
Observed ORCID: 0000-0003-3403-114X
OpenAlex ID: A5069945267
Willingness to pay for QALY: perspectives and contexts in Japan
2019 · Ataru Igarashi, Rei Goto, et al. · Journal of Medical Economics · 41
PDF
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
2022 · Tatsuhiko Fujimoto, Kentaro Rikimaru, et al. · ACS Medicinal Chemistry Letters · 34
PDF
Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation
2017 · Mariko Yoneyama-Hirozane, Shin-ichi Matsumoto, et al. · Biochemical and Biophysical Research Communications · 33
PDF
A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices
2024 · Shiro Tanaka, Ataru Igarashi, et al. · Value in Health · 31
PDF
High-Throughput Screening to Identify Inhibitors of DEAD Box Helicase DDX41
2017 · Mariko Yoneyama-Hirozane, Mitsuyo Kondo, et al. · SLAS DISCOVERY · 22
Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis
2022 · Ataru Igarashi, Yosuke Nakano, et al. · Expert Review of Vaccines · 19
PDF
Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors
2017 · Mariko Yoneyama-Hirozane, Kohei Deguchi, et al. · SLAS DISCOVERY · 17
PDF
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023
2024 · Ataru Igarashi, Shiro Tanaka, et al. · Advances in Therapy · 13
PDF
Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives
2017 · Ayumu Niida, Yoko Kanematsu-Yamaki, et al. · Bioorganic & Medicinal Chemistry · 8
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations
2025 · Hiroaki Mamiya, Kittima Wattanakamolkul, et al. · PharmacoEconomics - Open · 6
PDF
Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn’s disease: a quantitative evaluation of patients and non-patients in Japan
2023 · Masafumi Kato, Mariko Yoneyama-Hirozane, et al. · Journal of Market Access & Health Policy · 6
PDF
Willingness to Pay for a Qaly With an Inquiry into the Different Perspectives and Contexts in Japan
2018 · A Igarashi, R Goto, et al. · Value in Health · 1
新規モダリティなどの革新的な医薬品の価値評価
2025 · Mariko Hirozane · Iryo To Shakai
PDF
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023
2025 · Ataru Igarashi, Shiro Tanaka, et al. · Advances in Therapy
PDF
EE557 A Systematic Review of Productivity Gain/Loss in Health Economic Evaluations: An Element for Value Assessment of Innovative Treatments
2024 · H Mamiya, K Wattanakamolkul, et al. · Value in Health
PDF
PCR175 Health-Related Quality of Life in Health States Corresponding to Different Stages of Perianal Fistula Associated with Crohn’S Disease: A Quantitative Evaluation of Patients and Non-Patients in Japan
2023 · M. Kato, M. Yoneyama-Hirozane, et al. · Value in Health
PDF
Public Preferences for Policy Measures to Protect the Public against Infectious Diseases: A Conjoint Analysis
2022 · Ataru Igarashi, Yosuke Nakano, et al. · Research Square
PDF
CCDC 2111149: Experimental Crystal Structure Determination
2022 · Fujimoto, Tatsuhiko, Rikimaru, Kentaro, et al. · The Cambridge Structural Database
The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan
2022 · Junichi Nishimura, Sadao Nagaoka, et al. · Journal of the Japanese and International Economies
PDF
Excess Death During COVID-19 Pandemic in Japan: A Preliminary Analysis
2020 · Ataru Igarashi, Ichiro Wada, et al. · SSRN Electronic Journal
Works count: 22
Citation count: 231
H-index: 8
I10-index: 8
Year
Topic
Type